Kieuhoa T. Vo, MD
Director, Early Phase Clinical Trials Program
Director, MIBG Therapy Program
Specialties: Pediatric solid tumors
Dr. Kieuhoa T. Vo is a pediatric hematologist-oncologist who cares for children with cancer and blood disorders.
Dr. Vo’s clinical and translational research career is focused on the development of novel prognostic and predictive biomarkers and the incorporation of these biomarkers into new clinical trials, working towards more effective and less toxic therapies in children and young adults with solid tumors.
She leads the clinical research program in pediatric solid tumors and oversees the MIBG radiotherapy program at UCSF. Dr. Vo is the Director of the Early Phase Clinical Trials Program in Pediatric Oncology. In this capacity, she is the site Principal Investigator for the national Children's Oncology Group Pediatric Early Phase Clinical Trials Network (COG PEP-CTN) and New Approaches to Neuroblastoma Therapy (NANT) consortia. Dr. Vo is also the site PI for multiple investigator-initiated and industry-sponsored trials.
Indiana University School of Medicine, MD, 2008
Nationwide Children's Hospital, Pediatric Residency, 2011
University of California, San Francisco, M.A.S., 2015
University of California, San Francisco, Pediatric Oncology/Hematology Fellowship, 2015
Associate Professor, Department of Pediatrics, UCSF Benioff Children’s Hospital
2008
Indiana University School of Medicine Tina Kwan Scholarship Award in Pediatrics
2013-present
Developmental Therapeutics Scholar, Alex’s Lemonade Stand Foundation Center of Excellence Grant